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Abstract  29 
Background: Palliative care is now part of Universal Health Coverage goals. Measurement 30 
of person-centred outcomes is central to determining quality and effectiveness. Guidance in 31 
psychometrics requires tools applied in new settings to have their properties tested. 32 
Aims: To translate staff and patient versions of the Palliative care Outcome Scale (POS 33 
version 2) into Thai, and to determine its psychometric properties among cancer patients in a 34 
Thai public hospital. 35 
Design: The Thai POS was subjected to cross-cultural translation: forward translation, 36 
backward translation, review by experts, and content validity index measurement. The 37 
patient-rated version was completed by N=379, and staff-rated version by N=379 nurses. We 38 
tested internal consistency, known-group comparison, responsiveness, and agreement. 39 
Setting/participants: n=379 Thai cancer patients admitted to Maharaj Nakorn Chiang Mai 40 
Hospital. 41 
Results: We found good internal consistency (Cronbach’s alpha=0.9), good discrimination 42 
between known groups (significant difference in scores between high and low performance 43 
status groups, Z ranged from -9.95 to -7.80, p<0.001), good responsiveness (improvements 44 
in at time 2, Z ranged from -14.01 to -6.31, p<0.001), and acceptable to good patient-staff 45 
agreement on ratings (weighted kappa range 0.31 to 0.73). 46 
Conclusion: The Thai POS is valid and reliable. These findings enable researchers and 47 
clinicians to apply the POS in primary research and routine clinical practice, to both determine 48 
the effectiveness of interventions and improve care. This is the first validation in the region of 49 
a multidimensional person-centred outcome measure designed specifically for patients and 50 
families with advanced disease.  51 
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Introduction 52 
Despite an estimated 93.7 cancer-related deaths per 100,000 population in Thailand (1), 53 
provision of palliative care is not yet fully integrated into the health system (2).  The quality of 54 
death in Thailand is ranked 44th among 80 countries (3). While much has been achieved, 55 
palliative care provision in Thailand must be improved to meet the WHO’s Universal Health 56 
Coverage goals (4). 57 
Patient-centred outcome measures (PCOMs) are an important mechanism to achieve quality 58 
and equity in health care (5), and are a route to reducing global inequalities in palliative care 59 
(6, 7) by enabling patients to raise concerns with health professionals and focusing on 60 
outcomes (8). Use of PCOM results in palliative care can increase referrals, improve 61 
symptom recognition, increase discussions on quality of life, and improve emotional and 62 
psychological patient outcomes (9).  63 
Outcome measures in palliative care must be specific to the symptoms and concerns related 64 
to incurable illness, and be adequately brief for completion (10). To ensure use of outcome 65 
measures in the field of palliative care that are consistent, and that reflect the concerns of our 66 
patient and family population, we should use existing tools that have sound properties rather 67 
than developing new ones (11). The palliative care measures revalidated in Thailand to date 68 
(Edmonton Symptom Assessment Schedule (12) and the Palliative Performance Scale (13)) 69 
do not cover all important domains in palliative care (14). The Palliative Outcome Scale 70 
(POS) is one of the most commonly used tools in research and clinical practice (15). This 71 
instrument is a core outcome measure assessing physical, psychological, social, and spiritual 72 
domains of palliative care patients. Additionally, the POS consists of patient-rated and staff-73 
rated questionnaires which can obtain information directly from patients or alternative 74 
information from staff when patients are too ill to complete a questionnaire by themselves. 75 
This strength is not found on other palliative care measures in Thailand. A review of the 76 
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theoretical dimensions concluded that the POS is one of the most valid, reliable and 77 
comprehensive tools in palliative care (16). It has a stable factor structure (17) and good 78 
sensitivity and specificity when screening for depression (18). POS is used to assess 79 
interventions, prevalence of symptoms, and palliative care needs among patients with cancer 80 
and non-malignant diseases in high, middle and low income countries (19, 20) and has good 81 
validity and reliability (21).  82 
When health measurement scales are used in populations outside their original validation, the 83 
psychometric properties may not remain constant (22). This study aimed to translate the 84 
POSv2 patient and staff versions into Thai, and to evaluate its psychometric properties: 85 
construct validity (known-group comparison), internal consistency, responsiveness, and 86 
patient-staff agreement on ratings. 87 
 88 
Methods 89 
We conducted this validation study in line with the COSMIN guidance (23), and the COSMIN 90 
quality checklist (24). COSMIN provides international consensus on taxonomy, terminology 91 
and definitions of health outcome measure properties to evaluate outcome measures in 92 
health care.. 93 
Setting/participants 94 
We recruited cancer patients admitted to Maharaj Nakorn Chiang Mai hospital referred to the 95 
Chiang Mai University hospital-based palliative care service. This service is delivered by a 96 
multidisciplinary health care team in order to manage physical, psychological, social and 97 
spiritual problems, in collaboration with local health service centres for continuity of care. 98 
Inclusion criteria were: patients diagnosed with cancer, receiving palliative care, able to 99 
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respond to questions in Thai, with sufficient cognitive and physical capacity to participate, and 100 
to provide written informed consent. 101 
Instrument 102 
The original POS V2 is an 11-item rating scale consisting of the staff and patient versions. 10 103 
items are used to assess physical symptoms, psychological symptoms, social problems and 104 
spirituality. The 11th item is an open-ended question asking about other problems.  105 
Cross-cultural translation 106 
POS V2 was selected by the clinical team as the preferred outcome measure due to its 107 
brevity and use of an open question. Cross-cultural translation consisted of forward 108 
translation, backward translation, review by experts, and pre-test, following best practice 109 
guidance (25). In this validation study we also asked the nurse to complete the Palliative 110 
Performance Scale (PPS) at Time 1 and 2 (26), as this is specific to palliative care and has 111 
been validated in Thaland (13), enabling us to conduct known-group comparison. .POS V2 112 
was translated into Thai by the first bilingual translator (a palliative care nurse). This was 113 
edited by the second bilingual translator (a linguist). This was back translated into English by 114 
the third bilingual translator (a linguist) who had not seen the original version. 115 
Comparison between the back-translated version and the original English version was 116 
conducted by the first two translators to examine the semantic, content and conceptual 117 
equivalence between these two versions (27). When any discrepancy between these two 118 
versions was identified, the back-translated version, and also the Thai version, were then 119 
modified by consensus from these two translators. The modified back-translated version was 120 
sent to POS research team (King’s College London) for external review, with no further 121 
suggested edits. 122 
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A pre-test was conducted to examine content validity and internal consistency. Five palliative 123 
care professionals reviewed both patient-rated and staff-rated questionnaires, and the content 124 
validity index (CVI) was calculated. 15 patients and nurses were asked to complete a patient-125 
rated and staff-rated questionnaire respectively, then internal consistency was calculated. 126 
Data collection 127 
Patients were recruited within three days of admission. Demographic data were collected 128 
through self-report and chart review. At T1 the patient asked to self-complete the patient 129 
version (with assistance as required), and the staff version was completed by their allocated 130 
nurse. At seven days, the same staff and patients completed a second POS (T2), and at a 131 
further seven days a third POS was completed (T3). Therefore the same nurse reported data 132 
on the patient at each timepoint. Data were entered into SPSS v22 for analysis.  133 
Analysis 134 
The exploration of validity and reliability followed best practice guidance for health 135 
measurement validation (23, 28). Before testing the psychometric properties, POS scores in 136 
this study were reversed for comparison with PPS scores (therefore higher POS scores 137 
reflected better outcomes and lower scores reflected worse outcomes). For construct validity, 138 
known-group comparison was tested. Known-group comparison sought to determine whether 139 
patients with low performance status (PPS scores below median) had total POS scores 140 
statistically significantly lower than patients with high performance status (PPS scores ≥ 141 
median). Because POS scores were non-normally distributed, Mann-Whitney U-test was 142 
used to evaluate whether total POS scores of were significantly different. A statistically 143 
significant level of p≤0.05) would indicate adequate discrimination between known groups.  144 
Internal consistency was evaluated by using Cronbach’s alpha, with a result ≥ 0.7 adequate 145 
to indicate adequate internal consistency (30). Responsiveness was assessed by observing 146 
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changes in POS scores over time. Changes in POS scores were examined (total score and 147 
for each item) between the first and the second assessment, and between second and the 148 
third assessment. Because scores were non-normally distributed data, Wilcoxon signed rank 149 
test was used to test the hypothesis that a statistically significant change would be observed 150 
between timepoints. 151 
The agreement on ratings was determined for staff and patient-report at each timepoint.  . 152 
The level of agreement for each item was assessed by calculating the percentage of 153 
agreement and Cohen’s linear quadratic weighted kappa, hypothesized to be ≥ 0.61 for at 154 
least substantial agreement (31). 155 
This research was approved by the Research Ethics Committee, Faculty of Medicine, Chiang 156 
Mai University (Research lD:945 / Study code No. NllR 12 945 EX). 157 
 158 
Results 159 
Sample characteristics 160 
We recruited N=379 patients with an average age of 53.9-years (see Table 1). Most patients 161 
had low education, low income, and received their clinical care through Government public 162 
welfare. The most common malignancies were bronchus and lung, liver and colon. The 163 
median PPS score of this sample was 80. 164 
INSERT TABLE 1 HERE 165 
Completeness of data 166 
POS data had very high levels of completion at the item level (see Tables 2 and 3) at Time 1 167 
and Time 2 (98.4-100% of items complete). However, only 45% of data could be collected at 168 
T3 because patients had been discharged. 169 
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Content validity 170 
The averaged CVI was reported as 0.96 for patient version and 0.95 for staff version, 171 
demonstrating good validity (32). 172 
Construct validity: known-group comparison 173 
At T1 and T2, total POS scores for the high-performance status group were significantly 174 
higher than those in the low-performance status group for both patient and staff versions (Z 175 
ranged from -9.95 to -7.80, p<0.001). 176 
Internal consistency 177 
Cronbach’s alpha at pre-test was 0.87 (n=15) for staff version and 0.89 (n=15) for patient 178 
version, and at T1 was 0.91 (n= 378) for staff version and 0.90 (n=379) for patient version, 179 
indicating good internal consistency (0.7-0.9=good internal consistency) (30).180 
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Responsiveness 181 
For responsiveness T1-T2, statistically significant changes were demonstrated for total score 182 
and all POS items (see Table 2 for staff version and Table 3 for patient version). For 183 
responsiveness T2-T3, there were statistically significant changes of total scores and all POS 184 
items scores except for the item “wasted time” in the staff version. 185 
INSERT TABLE 2 HERE 186 
INSERT TABLE 3 HERE 187 
Agreement on ratings 188 
At T1 and T2, the percentage of total agreement for all items ranged from 50.4% to 81.2%. 189 
Cohen’s weighted kappa of most items ranged from 0.46 to 0.73, indicating moderate to 190 
substantial agreement. The weighted kappa for items “family anxiety” and “wasted time” at T2 191 
ranged from 0.31 to 0.35 which indicates fair agreement (31) (see Table 4). 192 
INSERT TABLE 4 HERE 193 
 194 
Discussion 195 
This is the first validation of the POS in Southeast Asia (19, 20) and reports a large sample 196 
size. 197 
High CVI demonstrated in the pre-test confirmed that the Thai POS comprehensively 198 
represented palliative care outcomes in Thai culture, and was accepted by experts (33, 34). 199 
Additionally, the known-group comparison showed that the Thai POS can discriminate 200 
between patients with different clinical status (36). 201 
High internal consistency confirmed that items in the Thai translation of POS measure a 202 
similar concept (37). When compared to the original version, the internal consistency of the 203 
Thai POS is higher (Cronbach’s alphas of the original version = 0.65 and 0.7 for patient-rated 204 
and staff-rated questionnaire, respectively) (21). The explanation for this finding may be that 205 
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Thai patients may be more likely to have the mind-body linkage, compared to Western 206 
patients (where the original POS was developed). This explanation is supported by a study of 207 
symptom clusters in Thai cancer patients which found that pain, other physical symptoms, 208 
anxiety and depression were in the same symptom cluster (38), contrary to a study of UK 209 
cancer patients which found that pain and most of the physical symptoms were not in the 210 
same cluster as anxiety and depression (39). A symptom cluster is defined as symptoms 211 
which occur together and possibly share the same aetiology or mechanism (40).  212 
In terms of evaluating care, Thai POS is able to detect changes in outcomes (34) for all items. 213 
The assessment of patient-staff agreement on ratings demonstrated acceptable agreement 214 
for all items at T1 and for most items at T2, suggesting Thai POS is appropriate for use as a 215 
staff proxy for patients unable to self-report. Interestingly, substantial agreement was shown 216 
for the item “pain” at T1 and T2. This could be because pain is the hallmark of palliative care, 217 
distinguishing it from supportive care (41), it is most likely to have received careful monitoring 218 
and therefore awareness among staff. Although the item “family anxiety” and “wasted time” at 219 
T2 showed fair agreement (weighted kappa = 0.31 and 0.35 respectively), these kappas are 220 
within the range of weighted kappa for the original POS (0.22 to 0.58 at T1 and T2) (21). 221 
Additionally, kappas of these two items may be lower than actual values because the 222 
percentages of agreement of these two items were not particularly low (53.6 and 81.2). These 223 
paradoxical results may be caused by symmetrically unbalanced marginal totals for the 224 
contingency table of these two items (42). 225 
When compared with the Thai ESAS, internal consistency of Thai POS is higher (Cronbach’s 226 
alpha of the Thai ESAS is 0.75) (12). Additionally, in the assessment of face validity of the 227 
Thai ESAS, patients reported that the range of the numerical scale (0 to 10) was too wide for 228 
measurement of emotion, and the meaning of each scale point should be explained (12). So, 229 
the ordinal scale in the Thai POS may be better because it contains fewer response levels 230 
and the meaning of each scale point is explained. Furthermore, Thai POS covers more 231 
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palliative care domains, including communication, psychosocial support, and spirituality, and 232 
can be rated by both patients and staff, although the Thai ESAS measures more physical 233 
symptoms. We note that the newest version of POS (the IPOS) has an expanded symptom 234 
list.  235 
Some limitations of this study are that convergent validity, discriminant validity, test-retest 236 
reliability and appropriateness of Thai POS were not studied (although the very low amount of 237 
missing data during both patient self-complete and staff-complete suggests good 238 
appropriateness). For responsiveness, our analysis is based on an assumption of meaningful 239 
change within patients and we have no indicator of change other than the self-report POS 240 
data. Also, this study was conducted on only cancer patients admitted in a hospital, so the 241 
results may not be generalised to patients with chronic non-malignant diseases, and patients 242 
in other palliative care settings. Hence, future research should study these untested 243 
psychometric properties and should be conducted on a more heterogeneous population of 244 
adults with incurable progressive illness. 245 
 246 
Conclusion 247 
This study demonstrates that Thai POS is valid and reliable when used among Thai cancer 248 
patients. In the evaluation of psychometric properties, the results demonstrated that the Thai 249 
POS has good content validity, good discrimination between known groups, good internal 250 
consistency, good responsiveness, and acceptable patient-staff agreement on ratings. 251 
Furthermore, when selecting a tool to measure person-centred outcomes in palliative care in 252 
Thailand the Thai POS may be considered an appropriate choice as, compared to other 253 
measures, validated in Thailand it covers core domains of palliative care and has valid both 254 
patient and staff completion versions. We believe that the properties of the Thai POS will 255 
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enable clinicians to ensure that they direct and monitor care to reflects the priorities of 256 
patients and their families, support services to audit their provision of care, and at policy and 257 
Governmental level it can provide the evidence of effectiveness for models of care required 258 
by the World Health Assembly’s resolution on palliative care (43). Local validation of outcome 259 
measurement in low and middle-income countries can also catalyse research activity and 260 
outputs (44, 45). The Thai POS should be widely used in clinical practice, audit and research 261 
to advance the field of palliative care.  262 
 263 
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Table 1 Characteristics of patients 266 
  
Number of patients 379  
Age 
Mean (SD) 
Min - Max 
 
53.9 (13.1) 
15 - 89 
 
Gender 
Male 
Female 
 
199 (52.5%) 
180 (47.5%) 
 
Marital status 
Married 
Single/Widow/Divorce/Separate 
 
 
253 (66.8%) 
126 (33.2%) 
 
 
Education 
Primary or secondary school 
 
Bachelor or higher degree 
No education 
 
278 (73.4%) 
84 (22.2%) 
17 (4.5%) 
 
Income 
No income 
< 153 USD 
153 – 307 USD 
> 307 USD 
111 (29.3%) 
118 (31.1%) 
69 (18.2%) 
81 (21.4%) 
 
Health coverage * 
Government public welfareWelfare for 
Government officer/Public enterprise 
officer 
Pay by personal money 
Others 
 
215 (56.7%) 
118 (31.1%) 
 
41 (10.8%) 
4 (1.1%) 
 
Disease (Malignant neoplasm of) 
Bronchus and lung 
Liver 
Colon 
Hematopoietic tissue 
Head/Neck 
Bone and articular cartilage  
Lymphoid tissue 
Cervix uteri  
Breasts 
Others 
  
 
79 (20.8%) 
63 (16.6%) 
56 (14.8%) 
33 (8.7%) 
31 (8.2%) 
30 (7.9%) 
23 (6.1%) 
22 (5.8%) 
12 (3.2%) 
30 (7.9%) 
 
 
 
PPS** score at Time 1 
Median (interquartile) 
Min – Max 
 
80 (60 - 90) 
30 – 100 
 
* Missing data for 1 case 267 
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** PPS = Palliative Performance Scale  268 
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  269 
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Table 2 Responsiveness to change of the POS; Staff version (tested by Wilcoxon signed rank test) N=379 270 
 
Time 1 
Time 2 (Responsiveness between 
time 2 and time 1) 
Time 3 (Responsiveness between 
time 3 and time 2) 
 Mean 
(95% 
CI) 
Median 
(Interqua
rtile) 
n 
Mean 
(95% 
CI) 
Median 
(Interquar
tile) 
n Z p 
Mean 
(95% 
CI) 
Median 
(Interquar
tile) 
n Z p 
1. Pain 2.2 
(2.07-
2.34) 
2 
(1-3) 
379 
2.73 
(2.65-
2.81) 
3 
(2-3) 
37
9 
-8.33 <0.001 
2.96 
(2.89-
3.03) 
3 
(3-3) 
17
1 
-
6.57 
<0.00
1 
2. Other 
symptoms 
2.28 
(2.15-
2.15) 
2 
(1-3) 
379 
2.78 
(2.70-
2.85) 
3 
(2-3) 
37
9 
-8.08 <0.001 
3.32 
(3.23-
3.42) 
3 
(3-4) 
17
1 
-
7.23 
<0.00
1 
3. Patient 
anxiety 
2.34 
(2.23-
2.45) 
2 
(1-3) 
379 
2.86 
(2.78-
2.93) 
3 
(2-3) 
37
9 
-8.94 <0.001 
3.06 
(2.98-
3.13) 
3 
(3-3) 
17
1 
-
5.92 
<0.00
1 
4. Family 
anxiety 
2.10 
(1.98-
2.22) 
2 
(1-3) 
378 
2.88 
(2.81-
2.96) 
3 
(3-3) 
37
9 
-
10.3
6 a 
<0.001 
a 
3.32 
(3.21-
3.43) 
3 
(3-4) 
17
1 
-
7.09 
<0.00
1 
5. 
Information 
2.59 
(2.47-
2.70) 
2 
(2-4) 
379 
3.21 
(3.13-
3.30) 
3 
(3-4) 
37
9 
-9.57 <0.001 
3.55 
(3.45-
3.65) 
4 
(3-4) 
17
1 
-
6.55 
<0.00
1 
6. Sharing 
feeling 
2.29 
(2.17-
2.42) 
2 
(1-3) 
379 
2.88 
(2.79-
2.97) 
3 
(2-4) 
37
9 
-9.48 <0.001 
3.19 
(3.12-
3.27) 
3 
(3-3) 
17
1 
-
5.83 
<0.00
1 
7. 
Depression 
2.56 
(2.46-
2.67) 
2 
(2-4) 
379 
2.91 
(2.81-
3.00) 
3 
(2-4) 
37
9 
-6.59 <0.001 
3.11 
(3.01-
3.20) 
3 
(3-3) 
17
1 
-
6.33 
<0.00
1 
8. Self-
worth 
2.49 
(2.37-
2.60) 
2 
(2-4) 
379 
2.98 
(2.89-
3.08) 
3 
(2-4) 
37
8 
-9.71 <0.001 
3.30 
(3.19-
3.41) 
3 
(3-4) 
17
1  
-
6.69 
c 
<0.00
1 c 
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9. Wasted 
time 
1.61 
(1.44-
1.79) 
2 
(0-4) 
379 
3.67 
(3.58-
3.77) 
4 
(4-4) 
37
8 
-
13.6
6 a 
<0.001 
a 
3.80 
(3.68-
3.93) 
4 
(4-4) 
17
1 
-
1.45 
c 
0.147 
c 
10. 
Personal 
affairs 
2.49 
(2.37-
2.62) 
2 
(2-4) 
379 
2.91 
(2.80-
3.02) 
2 
(2-4) 
37
9 
-6.31 <0.001 
3.25 
(3.09-
3.40) 
4 
(2-4) 
17
0 
-
5.58 
<0.00
1 
Total 22.96 
(22.0
1-
23.91
) 
23 
(13-32) 
378 
29.82 
(29.2
7-
30.37
) 
30 
(26-34) 
37
8 
-
14.0
1 b 
<0.001 
b 
32.85 
(32.27-
33.44) 
34 
(32-34) 
17
0 
-
9.68 
d 
<0.00
1 d 
 271 
a 1 patient had missing data.     b 2 patients had missing data. c 1 patient had missing data.  d 2 patients had missing data. 272 
  273 
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Table 3 Responsiveness to change of the POS; Patient version (tested by Wilcoxon signed rank test) N=379 274 
 
Time 1 
Time 2 (Responsiveness between 
time 2 and time 1) 
Time 3 (Responsiveness between time 
3 and time 2) 
 Mea
n 
(95% 
CI) 
Median 
(Interquar
tile) 
n 
Mean 
(95% CI) 
Median 
(Interquar
tile) 
n  Z p 
Mean 
(95% CI) 
Median 
(Interquar
tile) 
n Z p 
1. Pain 2.16 
(2.03
-
2.29) 
2 
(1-3) 
37
9 
2.72 
(2.63-
2.80) 
3 
(2-3) 
37
9 
-
8.04 
<0.0
01 
3.17 
(3.05-
3.29) 
3 
(3-4) 
17
2 
-
6.85 
<0.00
1 
2. Other 
symptoms 
2.31 
(2.17
-
2.44) 
2 
(1-4) 
37
9 
2.83 
(2.75-
2.91) 
3 
(2-3) 
37
9 
-
7.72 
<0.0
01 
3.33 
(3.21-
3.44) 
3 
(3-4) 
17
2 
-
7.12 
<0.00
1 
3. Patient 
anxiety 
2.43 
(2.32
-
2.53) 
2 
(2-3) 
37
9 
2.85 
(2.77-
2.93) 
3 
(2-3) 
37
9 
-
7.49 
<0.0
01 
3.04 
(2.96-
3.12) 
3 
(3-3) 
17
1 
-
5.26 
<0.00
1 
4. Family 
anxiety 
2.15 
(2.02
-
2.27) 
2 
(1-3) 
37
9 
2.85 
(2.77-
2.94) 
3 
(2-3) 
37
7 
-
10.0
1 
<0.0
01  
2.95 
(2.86-
3.05) 
3 
(3-3) 
17
1 
-
3.04 
a  
0.002 
a 
5. 
Information 
2.71 
(2.59
-
2.82) 
2 
(2-4) 
37
9 
3.28 
(3.19-
3.37) 
4 
(3-4) 
37
9 
-
8.42 
<0.0
01 
3.85 
(3.77-
3.93) 
4 
(4-4) 
17
1 
-
7.60 
<0.00
1 
6. Sharing 
feeling 
2.31 
(2.19
-
2.44) 
2 
(1-4) 
37
9 
2.99 
(2.90-
3.08) 
3 
(2-4) 
37
7 
-
9.51  
<0.0
01  
3.13 
(3.05-
3.21) 
3 
(3-3) 
17
1 
-
3.40
b 
0.001 
b 
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7. 
Depression 
2.45 
(2.35
-
2.56) 
2 
(2-4) 
37
9 
2.91 
(2.81-
3.00) 
3 
(2-4) 
37
9 
-
8.59 
<0.0
01 
3.39 
(3.27-
3.50) 
4 
(3-4) 
17
1 
-
7.17 
<0.00
1 
8. Self-worth 2.57 
(2.45
-
2.69) 
2 
(2-4) 
37
9 
3.04 
(2.94-
3.14) 
3 
(2-4) 
37
9 
-
7.77 
<0.0
01 
3.42 
(3.29-
3.54) 
4 
(3-4) 
17
1 
-
6.79 
<0.00
1 
9. Wasted 
time 
1.74 
(1.56
-
1.92) 
2 
(0-4) 
37
9 
3.54 
(3.44-
3.64) 
4 
(4-4) 
37
8 
-
12.8
6 
<0.0
01  
3.87 
(3.78-
3.96) 
4 
(4-4) 
17
1 
-
4.32 
b 
<0.00
1 b 
10. Personal 
affairs 
2.44 
(2.31
-
2.58) 
2 
(2-4) 
37
9 
3.19 
(3.07-
3.30) 
4 
(2-4) 
37
6 
-
9.35 
<0.0
01  
3.29 
(3.13-
3.44) 
4 
(2-4) 
17
1 
-
3.02 
a 
0.003 
a 
Total 23.2
7 
(22.3
3-
24.2
1) 
24 
(14-31) 
37
9 
30.25 
(29.73-
30.78) 
30 
(26-34) 
37
3 
-
13.8
0 
<0.0
01  
33.41 
(32.74-
34.08) 
33 
(31-37) 
17
1 
-
9.71
c 
<0.00
1 c 
 275 
a 2 patients had missing data.  b 1 patient had missing data.  c 4 patients had missing data.276 
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Table 4 the percentage and level of patient-staff agreement on ratings 277 
 Time 1 Time 2 
 % total 
agreement 
Weighted 
Kappa 
p-
value 
n 
% total 
agreement 
Weighted 
Kappa 
p-
value 
n 
1. Pain 
67.5 0.686 <0.001 379 72.0 0.616 <0.001 379 
2. Other 
symptoms 57.3 0.578 
<0.001 379 64.6 0.473 <0.001 379 
3. Patient 
anxiety 52.5 0.554 
<0.001 379 63.9 0.455 <0.001 379 
4. Family 
anxiety 54.0 0.521 
<0.001 378 53.6 0.305 <0.001 377 
5. 
Information 63.6 0.583 
<0.001 379 66.8 0.472 <0.001 379 
6. Sharing 
feeling 50.4 0.522 
<0.001 379 60.5 0.456 <0.001 377 
7. 
Depression 54.1 0.476 
<0.001 379 68.1 0.548 <0.001 379 
8. Self-
worth 55.9 0.561 
<0.001 379 61.6 0.485 <0.001 378 
9. Wasted 
time 80.5 0.728 <0.001 379 81.2 0.349 <0.001 377 
10. 
Personal 
affairs 
73.6 0.559 <0.001 379 73.9 0.518 <0.001 376 
 278 
  279 
22 
 
Funding Statement 280 
No funding has been provided for this study. 281 
References 282 
1. World. GLOBOCAN 2012: Estimated cancer incidence, mortality and prevalence 283 
worldwide in 2012 2012 [Available from: 284 
http://globocan.iarc.fr/Pages/fact_sheets_population.aspx. 285 
2. Lynch T, Connor S, Clark D. Mapping levels of palliative care development: a global 286 
update. Journal of pain and symptom management. 2013;45(6):1094-106. 287 
3. Unit TEI. The 2015 Quality of Death Index Ranking palliative care across the world 288 
2015. 289 
4. Organisation. WH. Universal Health Coverage  [Available from: 290 
http://www.who.int/mediacentre/factsheets/fs395/en/. 291 
5. Dawson J, Doll H, Fitzpatrick R, Jenkinson C, Carr AJ. The routine use of patient 292 
reported outcome measures in healthcare settings. BMJ. 2010;340:c186. 293 
6. World Health Assembly. WHO Strengthening of palliative care as a component of 294 
comprehensive care throughout the life course, 2014 Geneva2014 [cited 2016 16/05/2016]. 295 
Available from: http://apps.who.int/gb/ebwha/pdf_files/WHA67/A67_R19-en.pdf. 296 
7. Knaul FM, Farmer PE, Krakauer EL, De Lima L, Bhadelia A, Jiang Kwete X, et al. 297 
Alleviating the access abyss in palliative care and pain relief-an imperative of universal health 298 
coverage: the Lancet Commission report. Lancet. 2017. 299 
8. Greenhalgh J. The applications of PROs in clinical practice: what are they, do they 300 
work, and why? Qual Life Res. 2009;18(1):115-23. 301 
9. Etkind SN, Daveson BA, Kwok W, Witt J, Bausewein C, Higginson IJ, et al. Capture, 302 
transfer, and feedback of patient-centered outcomes data in palliative care populations: does it 303 
make a difference? A systematic review. J Pain Symptom Manage. 2015;49(3):611-24. 304 
10. Bausewein C, Simon ST, Benalia H, Downing J, Mwangi-Powell FN, Daveson BA, et 305 
al. Implementing patient reported outcome measures (PROMs) in palliative care--users' cry for 306 
help. Health Qual Life Outcomes. 2011;9:27. 307 
11. Daveson BA, Simon ST, Benalia H, Downing J, Higginson IJ, Harding R, et al. Are we 308 
heading in the same direction? European and African doctors' and nurses' views and 309 
experiences regarding outcome measurement in palliative care. Palliative Medicine. 310 
2012;26(3):242-9. 311 
12. Chinda M, Jaturapatporn D, Kirshen AJ, Udomsubpayakul U. Reliability and validity 312 
of a Thai version of the edmonton symptom assessment scale (ESAS-Thai). Journal of pain 313 
and symptom management. 2011;42(6):954-60. 314 
13. Chewaskulyong B, Sapinun L, Downing GM, Intaratat P, Lesperance M, Leautrakul S, 315 
et al. Reliability and validity of the Thai translation (Thai PPS Adult Suandok) of the 316 
Palliative Performance Scale (PPSv2). Palliative medicine. 2012;26(8):1034-41. 317 
14. Hearn J, Higginson IJ. Outcome measures in palliative care for advanced cancer 318 
patients: a review. Journal of public health medicine. 1997;19(2):193-9. 319 
15. Collins ES, Witt J, Bausewein C, Daveson BA, Higginson IJ, Murtagh FE. A 320 
Systematic Review of the Use of the Palliative Care Outcome Scale and the Support Team 321 
Assessment Schedule in Palliative Care. J Pain Symptom Manage. 2015;50(6):842-53.e19. 322 
23 
 
16. Catania G, Costantini M, Beccaro M, Bagnasco A, Sasso L. Does quality of life 323 
assessment in palliative care look like a complex screening program? Health Qual Life 324 
Outcomes. 2013;11:7. 325 
17. Siegert RJ, Gao W, Walkey FH, Higginson IJ. Psychological well-being and quality of 326 
care: a factor-analytic examination of the palliative care outcome scale. J Pain Symptom 327 
Manage. 2010;40(1):67-74. 328 
18. Antunes B, Murtagh F, Bausewein C, Harding R, Higginson I, EUROImpact bo. 329 
Screening for Depression in advanced disease: psychometric properties of two items of 330 
the Palliative care Outcome Scale (POS).  European Association of Palliative Care; Lleida, 331 
SPain2014. 332 
19. Bausewein C, Le Grice C, Simon S, Higginson I, Prisma. The use of two common 333 
palliative outcome measures in clinical care and research: a systematic review of POS and 334 
STAS. Palliative medicine. 2011;25(4):304-13. 335 
20. Collins ES, Witt J, Bausewein C, Daveson BA, Higginson IJ, Murtagh FE. A 336 
Systematic Review of the Use of the Palliative Care Outcome Scale and the Support Team 337 
Assessment Schedule in Palliative Care. Journal of pain and symptom management. 338 
2015;50(6):842-53 e19. 339 
21. Hearn J, Higginson IJ. Development and validation of a core outcome measure for 340 
palliative care: the palliative care outcome scale. Quality in health care : QHC. 1999;8(4):219-341 
27. 342 
22. Streiner DL, Kottner J. Recommendations for reporting the results of studies of 343 
instrument and scale development and testing. J Adv Nurs. 2014;70(9):1970-9. 344 
23. Mokkink LB, Terwee CB, Patrick DL, Alonso J, Stratford PW, Knol DL, et al. The 345 
COSMIN study reached international consensus on taxonomy, terminology, and definitions of 346 
measurement properties for health-related patient-reported outcomes. J Clin Epidemiol. 347 
2010;63(7):737-45. 348 
24. Mokkink LB, Terwee CB, Knol DL, Stratford PW, Alonso J, Patrick DL, et al. The 349 
COSMIN checklist for evaluating the methodological quality of studies on measurement 350 
properties: a clarification of its content. BMC Med Res Methodol. 2010;10:22. 351 
25. Antunes B, Brown A, Witt J, Daveson B, Ramsenthaler C, Benalia H, et al. The 352 
Palliative care Outcome Scale family of measures; Manual for cross-cultural adaptation and 353 
psychometric validation London2012 [Available from: http://pos-pal.org/Resources.php. 354 
26. Ho F, Lau F, Downing MG, Lesperance M. A reliability and validity study of the 355 
Palliative Performance Scale. BMC Palliat Care. 2008;7(10). 356 
27. Sousa VD, Rojjanasrirat W. Translation, adaptation and validation of instruments or 357 
scales for use in cross-cultural health care research: a clear and user-friendly guideline. J Eval 358 
Clin Pract. 2011;17(2):268-74. 359 
28. Terwee CB, Bot SD, de Boer MR, van der Windt DA, Knol DL, Dekker J, et al. 360 
Quality criteria were proposed for measurement properties of health status questionnaires. J 361 
Clin Epidemiol. 2007;60(1):34-42. 362 
29. Swinkels RA, Bouter LM, Oostendorp RA, Swinkels-Meewisse IJ, Dijkstra PU, de Vet 363 
HC. Construct validity of instruments measuring impairments in body structures and function 364 
in rheumatic disorders: which constructs are selected for validation? A systematic review. Clin 365 
Exp Rheumatol. 2006;24(1):93-102. 366 
30. Nunnally JC, Bernstein IH. Psychometric theory. 3rd ed. New York: McGraw-Hill; 367 
1994. xxiv, 752 p. p. 368 
24 
 
31. Landis JR, Koch GG. The measurement of observer agreement for categorical data. 369 
Biometrics. 1977;33(1):159-74. 370 
32. Polit DF, Beek CT, Owen SV. Is the CVI an acceptable indicator of content validity? 371 
Appraisal and recommendations. Res Nurs Health. 2007;30(4):459-67. 372 
33. Guyatt GH, Feeny DH, Patrick DL. Measuring health-related quality of life. Ann 373 
Intern Med. 1993;118(8):622-9. 374 
34. Hays R, Revicki D. Reliability and validity (including responsiveness). In: Fayers PM, 375 
Hays RD, editors. Assessing quality of life in clinical trials : methods and practice. 2nd ed. 376 
Oxford ; New York: Oxford University Press; 2004. p. 25-40. 377 
35. Bowling A. Research methods in health : investigating health and health services. 4th 378 
ed. Berkshire: Open University Press; 2014. 379 
36. Roach KE. Measurement of health outcomes: reliability, validity and responsiveness. 380 
Journal of Prosthetics & Orthotics. 2006;18(6):P8-P12. 381 
37. Higginson IJ, Harding R. Outcome measurement. In: Addington-Hall JM, Bruera E, 382 
Higginson IJ, Payne S, editors. Research methods in palliative care. Oxford: Oxford 383 
University Press; 2007. p. 99-110. 384 
38. Chaiviboontham S. Symptom Clusters in Thais with Advanced Cancer. Pacific Rim 385 
International Journal of Nursing Research. 2011;15(4):265-77  386 
39. Molassiotis A, Wengstrom Y, Kearney N. Symptom cluster patterns during the first 387 
year after diagnosis with cancer. Journal of pain and symptom management. 2010;39(5):847-388 
58. 389 
40. Miaskowski C, Dodd M, Lee K. Symptom clusters: the new frontier in symptom 390 
management research. J Natl Cancer Inst Monogr. 2004(32):17-21. 391 
41. Gysels M, Higginson IJ. Improving Supportive and Palliative Care for Adults with 392 
Cancer: Research Evidence. London: National Institute for Clinical Excellence; 2004. 393 
42. Feinstein AR, Cicchetti DV. High agreement but low kappa: I. The problems of two 394 
paradoxes. J Clin Epidemiol. 1990;43(6):543-9. 395 
43. Strengthening of palliative care as a component of comprehensive care throughout the 396 
life course WHA67.19 2014 [Available from: 397 
http://apps.who.int/gb/ebwha/pdf_files/WHA67/A67_R19-en.pdf. 398 
44. Harding R, Selman L, Agupio G, Dinat N, Downing J, Gwyther L, et al. Validation of 399 
a core outcome measure for palliative care in Africa: the APCA African Palliative Outcome 400 
Scale. Health Qual Life Outcomes. 2010;8:10. 401 
45. Harding R, Selman L, Powell RA, Namisango E, Downing J, Merriman A, et al. 402 
Research into palliative care in sub-Saharan Africa. Lancet Oncol. 2013;14(4):e183-8. 403 
 404 
 405 
